{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:14:56Z","timestamp":1791112496948,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,5,13]],"date-time":"2010-05-13T00:00:00Z","timestamp":1273708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,5,13]],"date-time":"2010-05-13T00:00:00Z","timestamp":1273708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1038\/gt.2010.71","type":"journal-article","created":{"date-parts":[[2010,5,13]],"date-time":"2010-05-13T21:06:20Z","timestamp":1273784780000},"page":"1294-1308","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington's disease"],"prefix":"10.1038","volume":"17","author":[{"given":"A","family":"Giralt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H C","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Caneda-Ferr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Urb\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Canals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Alberch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,13]]},"reference":[{"key":"BFgt201071_CR1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72: 971\u2013983.","journal-title":"Cell"},{"key":"BFgt201071_CR2","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","volume":"85","author":"A Reiner","year":"1988","unstructured":"Reiner A, Albin RL, Anderson KD, D\u2019Amato CJ, Penney JB, Young AB . Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci USA 1988; 85: 5733\u20135737.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201071_CR3","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson Jr EP . Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985; 44: 559\u2013577.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFgt201071_CR4","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1523\/JNEUROSCI.3920-03.2004","volume":"24","author":"ZC Baquet","year":"2004","unstructured":"Baquet ZC, Gorski JA, Jones KR . Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J Neurosci 2004; 24: 4250\u20134258.","journal-title":"J Neurosci"},{"key":"BFgt201071_CR5","doi-asserted-by":"publisher","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","volume":"24","author":"JM Canals","year":"2004","unstructured":"Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Martin-Ibanez R, Munoz MT et al. Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease. J Neurosci 2004; 24: 7727\u20137739.","journal-title":"J Neurosci"},{"key":"BFgt201071_CR6","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.mcn.2003.11.012","volume":"25","author":"N Gavalda","year":"2004","unstructured":"Gavalda N, Perez-Navarro E, Gratacos E, Comella JX, Alberch J . Differential involvement of phosphatidylinositol 3-kinase and p42\/p44 mitogen activated protein kinase pathways in brain-derived neurotrophic factor-induced trophic effects on cultured striatal neurons. Mol Cell Neurosci 2004; 25: 460\u2013468.","journal-title":"Mol Cell Neurosci"},{"key":"BFgt201071_CR7","doi-asserted-by":"publisher","first-page":"11758","DOI":"10.1523\/JNEUROSCI.2461-07.2007","volume":"27","author":"AD Strand","year":"2007","unstructured":"Strand AD, Baquet ZC, Aragaki AK, Holmans P, Yang L, Cleren C et al. Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration. J Neurosci 2007; 27: 11758\u201311768.","journal-title":"J Neurosci"},{"key":"BFgt201071_CR8","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/39885","volume":"389","author":"CA Altar","year":"1997","unstructured":"Altar CA, Cai N, Bliven T, Juhasz M, Conner JM, Acheson AL et al. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 1997; 389: 856\u2013860.","journal-title":"Nature"},{"key":"BFgt201071_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1523\/JNEUROSCI.21-01-00117.2001","volume":"21","author":"JM Canals","year":"2001","unstructured":"Canals JM, Checa N, Marco S, Akerud P, Michels A, Perez-Navarro E et al. Expression of brain-derived neurotrophic factor in cortical neurons is regulated by striatal target area. J Neurosci 2001; 21: 117\u2013124.","journal-title":"J Neurosci"},{"key":"BFgt201071_CR10","doi-asserted-by":"publisher","first-page":"12748","DOI":"10.1523\/JNEUROSCI.3873-06.2006","volume":"26","author":"D del Toro","year":"2006","unstructured":"del Toro D, Canals JM, Gines S, Kojima M, Egea G, Alberch J . Mutant huntingtin impairs the post-Golgi trafficking of brain-derived neurotrophic factor but not its Val66Met polymorphism. J Neurosci 2006; 26: 12748\u201312757.","journal-title":"J Neurosci"},{"key":"BFgt201071_CR11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","volume":"118","author":"LR Gauthier","year":"2004","unstructured":"Gauthier LR, Charrin BC, Borrell-Pages M, Dompierre JP, Rangone H, Cordelieres FP et al. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 2004; 118: 127\u2013138.","journal-title":"Cell"},{"key":"BFgt201071_CR12","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1126\/science.1059581","volume":"293","author":"C Zuccato","year":"2001","unstructured":"Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L et al. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 2001; 293: 493\u2013498.","journal-title":"Science"},{"key":"BFgt201071_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ng1219","volume":"35","author":"C Zuccato","year":"2003","unstructured":"Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, Conti L et al. Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet 2003; 35: 76\u201383.","journal-title":"Nat Genet"},{"key":"BFgt201071_CR14","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.neuroscience.2007.11.044","volume":"152","author":"Z De March","year":"2008","unstructured":"De March Z, Zuccato C, Giampa C, Patassini S, Bari M, Gasperi V et al. Cortical expression of brain derived neurotrophic factor and type-1 cannabinoid receptor after striatal excitotoxic lesions. Neuroscience 2008; 152: 734\u2013740.","journal-title":"Neuroscience"},{"key":"BFgt201071_CR15","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","volume":"105","author":"K Gharami","year":"2008","unstructured":"Gharami K, Xie Y, An JJ, Tonegawa S, Xu B . Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice. J Neurochem 2008; 105: 369\u2013379.","journal-title":"J Neurochem"},{"key":"BFgt201071_CR16","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.neuroscience.2006.04.013","volume":"141","author":"TY Pang","year":"2006","unstructured":"Pang TY, Stam NC, Nithianantharajah J, Howard ML, Hannan AJ . Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice. Neuroscience 2006; 141: 569\u2013584.","journal-title":"Neuroscience"},{"key":"BFgt201071_CR17","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1523\/JNEUROSCI.1658-03.2004","volume":"24","author":"TL Spires","year":"2004","unstructured":"Spires TL, Grote HE, Varshney NK, Cordery PM, Van DA, Blakemore C et al. Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism. J Neurosci 2004; 24: 2270\u20132276.","journal-title":"J Neurosci"},{"key":"BFgt201071_CR18","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.neuroscience.2008.11.024","volume":"158","author":"A Giralt","year":"2009","unstructured":"Giralt A, Rodrigo T, Martin ED, Gonzalez JR, Mila M, Cena V et al. Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipaseCgamma activity and glutamate receptor expression. Neuroscience 2009; 158: 1234\u20131250.","journal-title":"Neuroscience"},{"key":"BFgt201071_CR19","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1523\/JNEUROSCI.5113-06.2007","volume":"27","author":"G Lynch","year":"2007","unstructured":"Lynch G, Kramar EA, Rex CS, Jia Y, Chappas D, Gall CM et al. Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease. J Neurosci 2007; 27: 4424\u20134434.","journal-title":"J Neurosci"},{"key":"BFgt201071_CR20","first-page":"195","volume":"146","author":"J Alberch","year":"2004","unstructured":"Alberch J, Perez-Navarro E, Canals JM . Neurotrophic factors in Huntington's disease. Prog Brain Res 2004; 146: 195\u2013229.","journal-title":"Prog Brain Res"},{"key":"BFgt201071_CR21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","volume":"81","author":"C Zuccato","year":"2007","unstructured":"Zuccato C, Cattaneo E . Role of brain-derived neurotrophic factor in Huntington's disease. Prog Neurobiol 2007; 81: 294\u2013330.","journal-title":"Prog Neurobiol"},{"key":"BFgt201071_CR22","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.pneurobio.2009.04.005","volume":"90","author":"R Schwarcz","year":"2010","unstructured":"Schwarcz R, Guidetti P, Sathyasaikumar KV, Muchowski PJ . Of mice, rats and men: revisiting the quinolinic acid hypothesis of Huntington's disease. Prog Neurobiol 2010; 90: 230\u2013245.","journal-title":"Prog Neurobiol"},{"key":"BFgt201071_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.expneurol.2007.08.019","volume":"209","author":"O Lindvall","year":"2008","unstructured":"Lindvall O, Wahlberg LU . Encapsulated cell biodelivery of GDNF: a novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease? Exp Neurol 2008; 209: 82\u201388.","journal-title":"Exp Neurol"},{"key":"BFgt201071_CR24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1006\/exnr.1997.6657","volume":"148","author":"MK Carpenter","year":"1997","unstructured":"Carpenter MK, Winkler C, Fricker R, Emerich DF, Wong SC, Greco C et al. Generation and transplantation of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice. Exp Neurol 1997; 148: 187\u2013204.","journal-title":"Exp Neurol"},{"issue":"Suppl","key":"BFgt201071_CR25","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1038\/nm1064","volume":"10","author":"O Lindvall","year":"2004","unstructured":"Lindvall O, Kokaia Z, Martinez-Serrano A . Stem cell therapy for human neurodegenerative disorders\u2014how to make it work. Nat Med 2004; 10 (Suppl): S42\u2013S50.","journal-title":"Nat Med"},{"key":"BFgt201071_CR26","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1089\/10430349950016393","volume":"10","author":"AP Bemelmans","year":"1999","unstructured":"Bemelmans AP, Horellou P, Pradier L, Brunet I, Colin P, Mallet J . Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer. Hum Gene Ther 1999; 10: 2987\u20132997.","journal-title":"Hum Gene Ther"},{"key":"BFgt201071_CR27","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ymthe.2004.02.016","volume":"9","author":"AP Kells","year":"2004","unstructured":"Kells AP, Fong DM, Dragunow M, During MJ, Young D, Connor B . AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease. Mol Ther 2004; 9: 682\u2013688.","journal-title":"Mol Ther"},{"key":"BFgt201071_CR28","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1602\/neurorx.1.4.394","volume":"1","author":"SB Dunnett","year":"2004","unstructured":"Dunnett SB, Rosser AE . Cell therapy in Huntington's disease. NeuroRx 2004; 1: 394\u2013405.","journal-title":"NeuroRx"},{"key":"BFgt201071_CR29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.brainresbull.2006.10.019","volume":"72","author":"SB Dunnett","year":"2007","unstructured":"Dunnett SB, Rosser AE . Cell transplantation for Huntington's disease. Should we continue? Brain Res Bull 2007; 72: 132\u2013147.","journal-title":"Brain Res Bull"},{"key":"BFgt201071_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0006-8993(95)00596-I","volume":"691","author":"Y Yoshimoto","year":"1995","unstructured":"Yoshimoto Y, Lin Q, Collier TJ, Frim DM, Breakefield XO, Bohn MC . Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease. Brain Res 1995; 691: 25\u201336.","journal-title":"Brain Res"},{"key":"BFgt201071_CR31","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/1096-9861(20010219)430:4<485::AID-CNE1045>3.0.CO;2-6","volume":"430","author":"M Kusakabe","year":"2001","unstructured":"Kusakabe M, Mangiarini L, Laywell ED, Bates GP, Yoshiki A, Hiraiwa N et al. Loss of cortical and thalamic neuronal tenascin-C expression in a transgenic mouse expressing exon 1 of the human Huntington disease gene. J Comp Neurol 2001; 430: 485\u2013500.","journal-title":"J Comp Neurol"},{"key":"BFgt201071_CR32","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/cne.20680","volume":"490","author":"EC Stack","year":"2005","unstructured":"Stack EC, Kubilus JK, Smith K, Cormier K, Del Signore SJ, Guelin E et al. Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington's disease transgenic mice. J Comp Neurol 2005; 490: 354\u2013370.","journal-title":"J Comp Neurol"},{"key":"BFgt201071_CR33","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1523\/JNEUROSCI.23-06-02193.2003","volume":"23","author":"ZX Yu","year":"2003","unstructured":"Yu ZX, Li SH, Evans J, Pillarisetti A, Li H, Li XJ . Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease. J Neurosci 2003; 23: 2193\u20132202.","journal-title":"J Neurosci"},{"key":"BFgt201071_CR34","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s11481-006-9020-8","volume":"1","author":"RN Saha","year":"2006","unstructured":"Saha RN, Liu X, Pahan K . Up-regulation of BDNF in astrocytes by TNF-alpha: a case for the neuroprotective role of cytokine. J Neuroimmune Pharmacol 2006; 1: 212\u2013222.","journal-title":"J Neuroimmune Pharmacol"},{"key":"BFgt201071_CR35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/sj.gt.3302847","volume":"14","author":"JR Pineda","year":"2007","unstructured":"Pineda JR, Rubio N, Akerud P, Urban N, Badimon L, Arenas E et al. Neuroprotection by GDNF-secreting stem cells in a Huntington's disease model: optical neuroimage tracking of brain-grafted cells. Gene Therapy 2007; 14: 118\u2013128.","journal-title":"Gene Therapy"},{"key":"BFgt201071_CR36","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0014-5793(97)00313-X","volume":"407","author":"M Okabe","year":"1997","unstructured":"Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y . \u2018Green mice\u2019 as a source of ubiquitous green cells. FEBS Lett 1997; 407: 313\u2013319.","journal-title":"FEBS Lett"},{"key":"BFgt201071_CR37","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.bbr.2007.02.030","volume":"179","author":"MD Dobrossy","year":"2007","unstructured":"Dobrossy MD, Dunnett SB . The corridor task: striatal lesion effects and graft-mediated recovery in a model of Huntington's disease. Behav Brain Res 2007; 179: 326\u2013330.","journal-title":"Behav Brain Res"},{"key":"BFgt201071_CR38","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.nurt.2008.01.008","volume":"5","author":"OR Adam","year":"2008","unstructured":"Adam OR, Jankovic J . Symptomatic treatment of Huntington disease. Neurotherapeutics 2008; 5: 181\u2013197.","journal-title":"Neurotherapeutics"},{"key":"BFgt201071_CR39","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1517\/14656566.5.4.767","volume":"5","author":"RM Bonelli","year":"2004","unstructured":"Bonelli RM, Hofmann P . A review of the treatment options for Huntington's disease. Expert Opin Pharmacother 2004; 5: 767\u2013776.","journal-title":"Expert Opin Pharmacother"},{"key":"BFgt201071_CR40","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1517\/13543784.16.12.1933","volume":"16","author":"EC Stack","year":"2007","unstructured":"Stack EC, Ferrante RJ . Huntington's disease: progress and potential in the field. Expert Opin Investig Drugs 2007; 16: 1933\u20131953.","journal-title":"Expert Opin Investig Drugs"},{"key":"BFgt201071_CR41","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1046\/j.1471-4159.2001.00538.x","volume":"78","author":"E Gratacos","year":"2001","unstructured":"Gratacos E, Perez-Navarro E, Tolosa E, Arenas E, Alberch J . Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members. J Neurochem 2001; 78: 1287\u20131296.","journal-title":"J Neurochem"},{"key":"BFgt201071_CR42","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/gt.2008.23","volume":"15","author":"AP Kells","year":"2008","unstructured":"Kells AP, Henry RA, Connor B . AAV-BDNF mediated attenuation of quinolinic acid-induced neuropathology and motor function impairment. Gene Therapy 2008; 15: 966\u2013977.","journal-title":"Gene Therapy"},{"key":"BFgt201071_CR43","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1046\/j.1471-4159.2000.0752190.x","volume":"75","author":"E Perez-Navarro","year":"2000","unstructured":"Perez-Navarro E, Canudas AM, Akerund P, Alberch J, Arenas E . Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4\/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease. J Neurochem 2000; 75: 2190\u20132199.","journal-title":"J Neurochem"},{"key":"BFgt201071_CR44","doi-asserted-by":"publisher","first-page":"4906","DOI":"10.1073\/pnas.0811228106","volume":"106","author":"DA Simmons","year":"2009","unstructured":"Simmons DA, Rex CS, Palmer L, Pandyarajan V, Fedulov V, Gall CM et al. Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice. Proc Natl Acad Sci USA 2009; 106: 4906\u20134911.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201071_CR45","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/jnr.20344","volume":"78","author":"C Cepeda","year":"2004","unstructured":"Cepeda C, Starling AJ, Wu N, Nguyen OK, Uzgil B, Soda T et al. Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF. J Neurosci Res 2004; 78: 855\u2013867.","journal-title":"J Neurosci Res"},{"key":"BFgt201071_CR46","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.nbd.2007.10.003","volume":"29","author":"JF Torres-Peraza","year":"2008","unstructured":"Torres-Peraza JF, Giralt A, Garcia-Martinez JM, Pedrosa E, Canals JM, Alberch J . Disruption of striatal glutamatergic transmission induced by mutant huntingtin involves remodeling of both postsynaptic density and NMDA receptor signaling. Neurobiol Dis 2008; 29: 409\u2013421.","journal-title":"Neurobiol Dis"},{"key":"BFgt201071_CR47","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1006\/exnr.1993.1111","volume":"122","author":"D Hoffman","year":"1993","unstructured":"Hoffman D, Breakefield XO, Short MP, Aebischer P . Transplantation of a polymer-encapsulated cell line genetically engineered to release NGF. Exp Neurol 1993; 122: 100\u2013106.","journal-title":"Exp Neurol"},{"key":"BFgt201071_CR48","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1523\/JNEUROSCI.16-15-04604.1996","volume":"16","author":"A Martinez-Serrano","year":"1996","unstructured":"Martinez-Serrano A, Bjorklund A . Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells. J Neurosci 1996; 16: 4604\u20134616.","journal-title":"J Neurosci"},{"key":"BFgt201071_CR49","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1038\/sj.gt.3301028","volume":"6","author":"F Rubio","year":"1999","unstructured":"Rubio F, Kokaia Z, Arco A, Garcia-Simon M, Snyder E, Lindvall O et al. BDNF gene transfer to the mammalian brain using CNS-derived neural precursors. Gene Therapy 1999; 6: 1851\u20131866.","journal-title":"Gene Therapy"},{"key":"BFgt201071_CR50","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1006\/exnr.2002.7877","volume":"174","author":"LA Cunningham","year":"2002","unstructured":"Cunningham LA, Su C . Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease. Exp Neurol 2002; 174: 230\u2013242.","journal-title":"Exp Neurol"},{"key":"BFgt201071_CR51","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1111\/j.1460-9568.2005.04503.x","volume":"22","author":"C Ericson","year":"2005","unstructured":"Ericson C, Georgievska B, Lundberg C . Ex vivo gene delivery of GDNF using primary astrocytes transduced with a lentiviral vector provides neuroprotection in a rat model of Parkinson's disease. Eur J Neurosci 2005; 22: 2755\u20132764.","journal-title":"Eur J Neurosci"},{"key":"BFgt201071_CR52","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.expneurol.2004.06.027","volume":"190","author":"M Bosch","year":"2004","unstructured":"Bosch M, Pineda JR, Sunol C, Petriz J, Cattaneo E, Alberch J et al. Induction of GABAergic phenotype in a neural stem cell line for transplantation in an excitotoxic model of Huntington's disease. Exp Neurol 2004; 190: 42\u201358.","journal-title":"Exp Neurol"},{"key":"BFgt201071_CR53","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/cne.21515","volume":"505","author":"A Reiner","year":"2007","unstructured":"Reiner A, Del MN, Deng YP, Meade CA, Sun Z, Goldowitz D . R6\/2 neurons with intranuclear inclusions survive for prolonged periods in the brains of chimeric mice. J Comp Neurol 2007; 505: 603\u2013629.","journal-title":"J Comp Neurol"},{"key":"BFgt201071_CR54","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/jnr.20060","volume":"76","author":"H Wu","year":"2004","unstructured":"Wu H, Friedman WJ, Dreyfus CF . Differential regulation of neurotrophin expression in basal forebrain astrocytes by neuronal signals. J Neurosci Res 2004; 76: 76\u201385.","journal-title":"J Neurosci Res"},{"key":"BFgt201071_CR55","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1111\/j.1460-9568.2007.05625.x","volume":"25","author":"RA Henry","year":"2007","unstructured":"Henry RA, Hughes SM, Connor B . AAV-mediated delivery of BDNF augments neurogenesis in the normal and quinolinic acid-lesioned adult rat brain. Eur J Neurosci 2007; 25: 3513\u20133525.","journal-title":"Eur J Neurosci"},{"key":"BFgt201071_CR56","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1172\/JCI31778","volume":"117","author":"SR Cho","year":"2007","unstructured":"Cho SR, Benraiss A, Chmielnicki E, Samdani A, Economides A, Goldman SA . Induction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington disease. J Clin Invest 2007; 117: 2889\u20132902.","journal-title":"J Clin Invest"},{"key":"BFgt201071_CR57","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/341149a0","volume":"341","author":"J Leibrock","year":"1989","unstructured":"Leibrock J, Lottspeich F, Hohn A, Hofer M, Hengerer B, Masiakowski P et al. Molecular cloning and expression of brain-derived neurotrophic factor. Nature 1989; 341: 149\u2013152.","journal-title":"Nature"},{"key":"BFgt201071_CR58","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1073\/pnas.95.7.3978","volume":"95","author":"A Di Polo","year":"1998","unstructured":"Di Polo A, Aigner LJ, Dunn RJ, Bray GM, Aguayo AJ . Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Muller cells temporarily rescues injured retinal ganglion cells. Proc Natl Acad Sci USA 1998; 95: 3978\u20133983.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201071_CR59","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.brainres.2006.05.022","volume":"1104","author":"HA Lorenzi","year":"2006","unstructured":"Lorenzi HA, Reeves RH . Hippocampal hypocellularity in the Ts65Dn mouse originates early in development. Brain Res 2006; 1104: 153\u2013159.","journal-title":"Brain Res"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201071.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201071","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201071.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T09:58:36Z","timestamp":1648547916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,13]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["BFgt201071"],"URL":"https:\/\/doi.org\/10.1038\/gt.2010.71","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,13]]},"assertion":[{"value":"18 May 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}